Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 13 January 2021. John Babitt.

Executive Summary

EY expects a very active M&A activity for medtechs in 2021 – but also thinks 2020 was impressive for the sector, said the firm’s Americas medtech leader John Babitt.

“We believe 2020 was an impressive year for medtech, in spite of procedures getting postponed, as M&A firepower approached a historical high for the industry of nearly $500bn." – John Babitt, Americas medtech leader, EY

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts